Bloomage Biotech(SH:688363) Zheng Xing Xing Ye Ri Bao·2025-09-01 08:53Market Performance - The medical beauty sector increased by 2.03% on September 1, with Huaxi Biological leading the gains [1] - The Shanghai Composite Index closed at 3875.53, up 0.46%, while the Shenzhen Component Index closed at 12828.95, up 1.05% [1] Individual Stock Performance - Huaxi Biological (688363) closed at 58.90, with a rise of 2.97% and a trading volume of 82,200 shares, totaling a transaction value of 478 million yuan [1] - Aimei Ke (300896) closed at 196.90, up 1.51%, with a trading volume of 45,400 shares and a transaction value of 882 million yuan [1] - Jinbo Biological (832982) closed at 313.10, with a slight increase of 0.20%, trading 9,349.66 shares for a total of 291 million yuan [1] - *ST Meigu (000615) remained unchanged at 3.13, with a trading volume of 79,500 shares and a transaction value of 2.49 million yuan [1] Capital Flow Analysis - The medical beauty sector saw a net inflow of 65.1 million yuan from main funds, while retail funds experienced a net outflow of 32.6 million yuan [1] - Aimei Ke had a main fund net inflow of 45.58 million yuan, but retail funds saw a net outflow of 20.84 million yuan [2] - Huaxi Biological experienced a main fund net inflow of 25.20 million yuan, with retail funds also showing a net outflow of 15.53 million yuan [2] - *ST Meigu had a net outflow of 5.68 million yuan from main funds, but retail funds showed a net inflow of 3.74 million yuan [2]